Beijing Hotgen Biotech Co. Ltd. Class ASSE: 688068

"BEIJING HOTGEN BIOTECH CO., LTD."Announcement on Progress in Repurchasing Shares

Jul 2, 2026 · Issued by Beijing Hotgen Biotech Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Progress in Repurchasing Shares

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Beijing Hotgen Biotech Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining the "Drug Clinical Trial Approval Notice" for Subsidiary’s Innovative Drug SGT003 InjectionJun 18
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share RepurchaseMay 28
Announcement on Initial Share Repurchase by the Company via Call AuctionMay 26

All Beijing Hotgen Biotech Co. Ltd. Class A news releases